0148.KLSE Sunzen Biotech Bhd

Consumer Defensive Food Products Kuala Lumpur Exchange
0.2200 MYR
Close of Oct 29, 2026
0.2150 0.2730
Market cap
MYR 174M
P/E
22.0x
P/B
1.54x
ROE
3.6%
Dividend yield
0.89%
Fundamental score
1.6/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2024.

Is 0148.KLSE undervalued?

Graham number
Price0.2200
Graham value0.1793
Premium22.7%

0148.KLSE trades 22.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sunzen Biotech Bhd fundamental analysis

8 of 22 checks passed

ROE 0/2

Low return on equity (3.6%), below 10%.

ROA 0/1

Return on assets (3.0%) is below the industry median (4.4%).

Profit Consistency 1/2

Profitable for 3 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (30.3%) is above the industry median (-1.6%).

Revenue Growth 1/2

Revenue grew 1.4% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (4.8%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 0/1

EBIT is negative, against interest expense, below 5x.

PE vs Market 0/1

PE (22.0x) is above the market median (11.4x).

PE vs Industry 0/1

PE (22.0x) is above the industry median (10.2x).

PBV 0/1

Price to book (1.5x) is above the industry median (0.8x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 33.9, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

About Sunzen Biotech Bhd

Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, and beauty and cosmetic products. It also offers financial consultancy services …

Full company profile